<DOC>
	<DOCNO>NCT02669901</DOCNO>
	<brief_summary>The purpose pilot-study distribute naloxone auto-injector `` Universal Precaution '' manner patient opioid substance use disorder . The objective decrease number fatal nonfatal overdose death , examine understand risk factor serious opioid toxicity overdose , evaluate unintentional opioid overdose risk utilize evidence-based screening questionnaire .</brief_summary>
	<brief_title>Naloxone Auto-injector Universal Precaution Patients With Opioid Substance Use Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Drug Overdose</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<criteria>All patient treat methadone , naltrexone buprenorphine medication assist treatment UNM Addiction Substance Abuse Program ( UNM ASAP ) age 18 old Subjects allergic naloxone inactive ingredient . Inactive ingredient include buffer agent . Subjects young 18 . Subjects treat UNM ASAP .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Opioid-Related Disorders</keyword>
	<keyword>Naloxone</keyword>
	<keyword>Harm Reduction</keyword>
	<keyword>Drug Overdose Deaths</keyword>
	<keyword>Opioid Misuse</keyword>
	<keyword>Naloxone Coprescribing</keyword>
	<keyword>Universal Precautions</keyword>
	<keyword>Opioid Substance Use Disorder</keyword>
</DOC>